Clinical Trial

Trial to Study Electro-Acupuncture in Subjects With Chemotherapy-Induced Peripheral Neuropathy

Completed
View on ClinicalTrials.gov →
Summary
This study will determine the feasibility and efficacy of a 10-treatment electro-acupuncture (EA) program in subjects with chemotherapy-induced peripheral neuropathy (CIPN). The Investigators hypothesize that EA will be a feasible and effective therapy for CIPN.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2026-03-02; most recent amendment 2026-04-29.
Trial Details
NCT Number NCT07455409
Lead Sponsor The Methodist Hospital Research Institute
Conditions Chemotherapy-induced Peripheral Neuropathy
Enrollment 20 participants
Start Date 2019-08-29
Primary Completion 2023-08-18 (estimated)
Study Completion 2023-08-18 (estimated)
Updated on ClinicalTrials.gov 2026-05-01